Trial Profile
A Randomized Double-Blind Placebo and Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs DS-1971 (Primary) ; Pregabalin
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 26 Jul 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 16 Feb 2016 New trial record